Donor Characteristics Associated With Graft Loss and Delayed Graft Function in Very-Aged Kidney Donors: An Observational Multicentric Study.
Mehdi Maanaoui, Rémi Lenain, Vivien Petit...
https://pubmed.ncbi.nlm.nih.gov/41340865/Actively Recruiting
Led by Nantes University Hospital · Updated on 2016-09-15
30000
Participants Needed
8
Research Sites
N/A
Total Duration
The French DIVAT cohort is a multicenter database started in 1994 by the Transplantation Urology Nephrology Institute of Nantes University Hospital. It collects detailed data on kidney transplant recipients to support clinical and epidemiological research, focusing on mid- and long-term outcomes, treatment strategies, and public health concerns. The cohort includes over 11,000 transplant recipients from 8 French university hospitals and tracks patient and graft data, including bio-banking since 2005. Participants are kidney transplant recipients monitored from the time of transplantation through scheduled outpatient visits or hospital admissions related to clinical, therapeutic, or biological changes. The database collects comprehensive medical records and biological samples to support research projects initiated through the DIVAT network, which encourages collaboration among researchers. During the study, participants medical information is continuously collected to assess outcomes such as overall survival at 2, 4, and 6 years, as well as immune cell changes over time. The DIVAT cohort supports ongoing monitoring and research to better understand and improve kidney transplantation outcomes. Participation involves data collection without additional interventions, and the study continues as long as the graft remains functional or until graft failure occurs.
CONDITIONS
Clinical Database Associated With a Biological Banking Accessible to Initiate Epidemiological and Translational Collaborative Researches in Kidney Transplantation
M
Magali Giral, PU-PH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Nantes University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 6 years
Participants who have undergone kidney transplantation are observed over several years to assess overall survival and immune cell changes.
Follow-up visits at 1 year, 2 years, 4 years, and 6 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Mehdi Maanaoui, Rémi Lenain, Vivien Petit...
https://pubmed.ncbi.nlm.nih.gov/41340865/Laureline Berthelot, Nicolas Degauque, Laura Cappelier...
https://pubmed.ncbi.nlm.nih.gov/41591822/Richard Danger, Ludmilla Le Berre, Marion Cadoux...
https://pubmed.ncbi.nlm.nih.gov/36990211/Corentin Choisy, Yohann Foucher, Christophe Masset...
https://pubmed.ncbi.nlm.nih.gov/40653616/Nantes University Hospital
Lead Sponsor